Lifecome Biochemistry Co.,Ltd.

Equities

002868

CNE100002QH2

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
16.67 CNY -3.25% Intraday chart for Lifecome Biochemistry Co.,Ltd. +0.30% -21.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Lifecome Biochemistry Co.,Ltd.(XSEC:002868) added to S&P Global BMI Index CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Lifecome Biochemistry Co.,Ltd. announced that it expects to receive CNY 1.3 billion in funding CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Kanyi Proposes Temporary Review of "Proposal on Expected Guarantee Limit for Subsidiaries in 2023" at Company's Extraordinary Shareholders' Meeting CI
Lifecome Biochemistry Resumes Factory Operations MT
Lifecome Biochemistry Co.,Ltd. completed the acquisition of Jiangxi Weike New Material Technology Co., Ltd. from Yushan County Wanghong Enterprise Management Center (Limited Partnership) and Wang Meijun. CI
HOP LIK INVESTMENT COMPANY LIMITED, Fujie Investment Co., Ltd. and Zhejiang Kangmin Enterprise Management Co., Ltd. completed the acquisition of Fujian Putan Thermal Energy Co., Ltd. from Lifecome Biochemistry Co.,Ltd.. CI
HOP LIK INVESTMENT COMPANY LIMITED, Fujie Investment Co., Ltd. and Zhejiang Kangmin Enterprise Management Co., Ltd. agreed to acquire Fujian Putan Thermal Energy Co., Ltd. from Lifecome Biochemistry Co.,Ltd. for approximately CNY 300 million CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Lifecome Biochemistry Nixes Plan to Buy New Materials, Thermal Energy Firms MT
A group of buyers singed a Cooperation Framework Agreement to acquire a 36.7% stake in Lifecome Biochemistry Co.,Ltd. from HOP LIK INVESTMENT COMPANY LIMITED, Fujie Investment Co., Ltd., and Beijing Kangmin Consulting Management Center (Limited Partnership) for approximately CNY 660 million. CI
Lifecome Biochemistry Co.,Ltd. entered into framework agreement to acquire 100% Jiangxi Weike New Material Technology Co., Ltd. from Yushan County Wanghong Enterprise Management Center (Limited Partnership) and Wang Meijun for CNY 95 million. CI
Lifecome Biochemistry Co.,Ltd. Approves Not to Pay Cash Dividend for 2021 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhongguancun Science-Tech to Buy, Lease Back Production Equipment of Veterinary Medicine MT
Lifecome Biochemistry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Lifecome Biochemistry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Lifecome Biochemistry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Chart Lifecome Biochemistry Co.,Ltd.
More charts
LIFECOME BIOCHEMISTRY CO LTD is a China-based company principally engaged in the development, production and sales of veterinary drugs. The Company's businesses include the production and sales of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives and biological pesticide. Its products include bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series and Jinggangmycin series. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002868 Stock
  4. News Lifecome Biochemistry Co.,Ltd.
  5. Lifecome Biochemistry Nixes Plan to Buy New Materials, Thermal Energy Firms